Companies / RNV

RENERVE LIMITED

ASX:RNVHealth Care Equipment & Services
173.5M shares on issueASX (delayed) · snapshot 28 Oct 2026221.5M fully diluted+27.6% if every option and right converts$0.090price · delayed$16.0MMarket capAt the previous close. On a day the price moves, shares × today’s price will differ. Prices delayed.

Today’s holders own 78.3% of what they think they own, once every option and right converts.

High
Dilution riskprovisional — limited history

Runway under 2 quarters; share count grew 22% in 24 months; 3 cash raises in 24 months

MinimalVery high
Absolute levels — not a ranking against other companies.
Cash runway1.1 quarters of funding
Share-count growth (24m)21.8%
Raise cadence (24m)3 cash raises
Options & rights overhang27.6% of shares
In-the-money supply0.0% of shares
Pending proposed issuesnone

Between March 2025 and October 2026, its latest share-count filing, RENERVE LIMITED's ordinary shares increased 21.8% to 174M shares. The company completed three capital raises in the past 24 months, totalling A$11.6M, most recently a Convertible note funding facility raising A$1.4M in July 2026. Options and rights could convert into 48M additional shares, representing a 27.6% overhang relative to the current issued capital, with none in the money and the nearest expiry in November 2027. The company has under 2 quarters of funding at the recent spend rate. No proposed securities issues are currently pending.

AI-generated summary of this page's cited filings · updated 28 Oct 2026
Quick answers · 5

When did RNV last raise capital?

The last capital raise in Renerve's filings is Convertible note funding facility of $1.4M announced 9 July 2026, one of 3 cash raises in 24 months.

How much placement capacity does RNV have left?

About 91% of the 15% placement capacity left, about 9% used in 12 months (estimate). Under ASX Listing Rule 7.1 a company may place up to 15% of its shares in 12 months without shareholder approval.

How much cash does RNV have?

In its quarterly cash report for the quarter ended 30 Sept 2026, Renerve reported $1.6M of cash and estimated 4.5 quarters of funding available at its current rate of spending. That is the company's own estimate.

When do RNV's options expire?

Unexercised options and rights equal 27.6% of Renerve's shares on issue; the nearest expiry is Nov 2027.

How much has RNV's share count grown?

Renerve has 173.5M shares on issue as at 28 Oct 2026, up 21.8% over 24 months according to its Appendix 2A filings.

Get told when this changes
Get RNV alerts
Free for up to 2 companies. A daily email when RNV raises money, files a new share issue, drops below 2 quarters of cash or moves risk level.
27.6%
Options & rights overhang
0.0%
In the moneyAn option whose exercise price is below the last closing share price, so converting it pays. These are the options most likely to become new shares soon. supply
2
Raises · last 12 months
1.1 qtrs
Cash cover · under 2 quarters

Shares on issue — last 2 years

Ordinary shares on issue
Weekly counts from ASX records. Dots mark cash capital raises. Latest count 173.5M per ASX (delayed) (snapshot 28 Oct 2026).
140M150M160M170MDec 24Nov 25Oct 26Cash raise · 9 July 2026Cash raise · 20 Nov 2025173.5M

Cash runway

1.1 qtrs OURS
Less than two quarters of funding at the recent spend rate — near-term funding pressure.
Funds operations to about Jan 2027 at the reported spend rate.
$1.3M cash after burn.
FILED 4.5 qtrs · $1.6M cash · quarter ended 30 Sept 2026
OURS our estimate, carried to todayOURSOur estimate for today. We take the cash in the company’s latest cash report, deduct spending since at its reported rate, and, for quarterly filers, add raises announced after it. It moves daily; announced money may not all be received yet.$1.6M cash at 30 Sep 2026 − $0.3M spent ($1.1M a quarter × 28 days) = $1.3M left → 1.1 qtrsFILED as the company reportedFILEDAs the company stated it in its latest cash report. Dated to the end of that period, it does not change until the next report.
Free account
8 cash reports on record — Cash runway history
Cash, net spend and cover trend from every Appendix 4C/5B and 4D/4E on record up to 30 Sept 2026.
Free account: 2 full company unlocks every month, no card.
Unlock RNV freeSee plans

Issuance timeline

Latest 5 filings (Appendix 2AThe form a company lodges to have new securities quoted on the ASX. It restates how many of each class are on issue. quoted issues, 3G unquoted, 3H cancellations)

DateFormSecurityOn issue, per this filingSource
28 Oct 20263G · unquotedRNV : ORDINARY FULLY PAID140.4MAppendix 3G
6 Oct 20263G · unquotedRNV : ORDINARY FULLY PAID140.2MAppendix 3G
6 Oct 20262A · quoted issueRNV : ORDINARY FULLY PAID140.4MAppendix 2A
25 Aug 20262A · quoted issueRNV : ORDINARY FULLY PAID140.2MAppendix 2A
13 July 20263G · unquotedRNV : ORDINARY FULLY PAID139.2MAppendix 3G

Each filing states the count for the security it names, as at its own reference date and in the units of that filing — so the newest row (140.4M) need not equal the current count above (173.5M).

Free account
21 filings on record — Full issuance history
Every quoted and unquoted issue and cancellation on record, plus unquoted securities (Appendix 4.2).
Free account: 2 full company unlocks every month, no card.
Unlock RNV freeSee plans

Securities on issue over time

Ordinary shares and every option and rights class, month by month over two years. The top edge is the fully diluted count.

Free account
Securities on issue, by class
How the share count and each option and rights class moved, month by month, with every number in a table.
Free account: 2 full company unlocks every month, no card.
Unlock RNV freeSee plans

Capital raises

3 cash raises in the last 24 months · 2 in the last 12 months

every 9.8 monthsaverage gap between raises
3.6 monthssince the most recent
22 Nov 2024 – 9 July 2026first to most recent in this window
$1.4M
Convertible note funding facility
9 July 2026 ACTIVE
Free account
10 raises on record — Full raise history
Issue price, shares issued, brokers and stated purpose for every raise on record.
Free account: 2 full company unlocks every month, no card.
Unlock RNV freeSee plans

Forward supply

Every dated event on record that could add securities to the register — option expiries to their stated dates and proposed issues over the next 18 months, on one timeline.

Free account
21 dated events on record — Forward supply calendar
Option expiries and proposed issues on one forward timeline, with the securities each could add.
Free account: 2 full company unlocks every month, no card.
Unlock RNV freeSee plans

Placement capacity

How much stock a company can place without asking holders. Listing Rule 7.1 / 7.1ARule 7.1 lets a company issue up to 15% of its shares in 12 months without a shareholder vote. Rule 7.1A adds 10% for smaller companies whose holders approve it. allows 15% of ordinary securities in any 12 months, and every Appendix 3BNotice that a company proposes to issue new securities, such as a placement. The securities are not on issue until a later filing confirms it. states how much of it an issue uses.

About 91% of the 15% placement capacity left — about 9% used by Appendix 3B filings in the last 12 months (estimate, as at 2026-10-28). The company has also placed under the additional 10% (Listing Rule 7.1A), which is not counted in this figure. Holders passed a ratification we could not match to exactly one filing, or whose number of shares the result does not state, and shares issued with holder approval are not added to the base, so the true headroom may be higher.
Free account
Placement capacity — LR 7.1 / 7.1A
The filings behind the figure: every Appendix 3B in the window with what it says was issued under 7.1 and 7.1A, each row linked to its filing, and how many shares are left.
Free account: 2 full company unlocks every month, no card.
Unlock RNV freeSee plans

Pending proposed issues

No proposed issues (Appendix 3B) currently pending.

Options & convertible securities

27.6%
Options & rights overhang · of current shares
0.0%
In-the-money supply · at current price
48.0M
Potential new shares
Nov 2027
Nearest expiry
What a price move would switch on
24.0M48.0M$0.090 now0.25× today ($0.022) — 0 of the priced supply in the money, 0.0% of shares on issue0.5× today ($0.045) — 0 of the priced supply in the money, 0.0% of shares on issue0.75× today ($0.068) — 0 of the priced supply in the money, 0.0% of shares on issue1× today ($0.090) — 0 of the priced supply in the money, 0.0% of shares on issue1.25× today ($0.112) — 0 of the priced supply in the money, 0.0% of shares on issue1.5× today ($0.135) — 33k of the priced supply in the money, 0.0% of shares on issue2× today ($0.180) — 1.9M of the priced supply in the money, 1.1% of shares on issue3× today ($0.270) — 38.8M of the priced supply in the money, 22.4% of shares on issue5× today ($0.450) — 42.4M of the priced supply in the money, 24.4% of shares on issue10× today ($0.900) — 43.2M of the priced supply in the money, 24.9% of shares on issue0.25×0.5×0.75×now1.25×1.5×2×3×5×10×

At $0.090 today, 0 securities are in the money (0.0% of shares on issue). No more priced supply until 1.5× today’s price, which takes it to 33k (0.0% of shares).

  • Priced supply in the money at the price on the axis — the curve, and the only thing on it. Ten prices, sampled: between two of them the true figure lies between the two.
  • 4.8M (10.0% of the supply above) states no exercise price at all. It cannot be called in or out of the money at any price, which is why it is hatched rather than plotted.
CodeSecurityTypeExercise priceExpiryOn issueSource
RNVAGOptionsPrice-triggered, no exercise price stated—22 Nov 20273.0MFiling
RNVAADOptionsPrice-triggered$0.1815 Jan 202826.7MFiling
RNVALOptionsPrice-triggered$0.2517 Apr 2028100kFiling
RNVAAEOptionsPrice-triggered$0.2415 Jan 20294.0MFiling
RNVAMOptionsPrice-triggered$0.351 July 2029150kFiling
RNVANOptionsPrice-triggered$0.3511 Sept 2029600kFiling
RNVAOOptionsPrice-triggered$0.121 Feb 203033kFiling
RNVAPOptionsPrice-triggered$0.151 Feb 203033kFiling
RNVAQOptionsPrice-triggered$0.201 Feb 203033kFiling
RNVAROptionsPrice-triggered$0.301 Feb 203033kFiling
RNVAAGOptionsPrice-triggered$0.156 Oct 20301.8MFiling
RNVAAHOptionsPrice-triggered$0.206 Oct 20301.8MFiling
RNVAAIOptionsPrice-triggered$0.256 Oct 20301.8MFiling
RNVASOptionsPrice-triggered$0.2024 Oct 2030123kFiling
RNVATOptionsPrice-triggered$0.2524 Oct 2030148kFiling
RNVAVOptionsPrice-triggered$0.3024 Oct 2030248kFiling
RNVAYOptionsPrice-triggered$0.202 Dec 20301.6MFiling
RNVAZOptionsPrice-triggered$0.252 Dec 2030538kFiling
RNVAAAOptionsPrice-triggered$0.302 Dec 20301.9MFiling
RNVAABOptionsPrice-triggered$0.402 Dec 2030640kFiling
RNVAACOptionsPrice-triggered$0.602 Dec 2030772kFiling
—OptionsPrice-triggered, no exercise price stated——1.8MFiling

“Nil” is a stated nil exercise price: nothing is paid to convert. An em dash means the filing names no exercise price at all. Security is read from the filing’s own class description; an em dash there means the description is not one this table labels. One row is one security class, at the number stated in the most recent quotation application that restated it — linked, and dated, in the last column. For what expires soon across other listed companies, see the options expiry calendar.

2 classes ceased in the last 12 months and are not counted above
The company’s own Appendix 2A restates each of these at zero. They are excluded from the overhang, the in-the-money supply and every figure on this page. Each count is the filing’s own count of securities in the class, not a share count — a 2A never states what one security converts into.
  • RNVAUPrice-triggered100k securities → 01 May 2026 Appendix 2A
  • RNVAXPrice-triggered50k securities → 012 Dec 2025 Appendix 2A
Also on issue: convertible debt, not counted above
These are debt. Each count is the filing’s own count of notes or units, not a share count, and how many shares they would become depends on terms we don’t hold in full (face value, interest, the conversion formula). So they are left out of the options overhang, the in-the-money supply and the parts of the risk score built on them. Placement capacity is different: the listing rules count a note issue at the most shares it can become.
Free account
23 option and convertible-debt lines on record — In-the-money value & price ladder
What each line is worth in the money today, the price ladder to the next tranche that converts, and the filing description behind every code.
Free account: 2 full company unlocks every month, no card.
Unlock RNV freeSee plans

Director dealings

DateDirectorTypeSharesOptionsOtherValueSource
6 Oct 2026Julian John ChickOther—3.0M——3Y notice
6 Oct 2026Maja McGuireOther—1.5M——3Y notice
6 Oct 2026Paul SavageOther—1.0M——3Y notice
Free account
14 notices on record — Full dealing history
Every change-of-director's-interest notice on record, with direction and consideration.
Free account: 2 full company unlocks every month, no card.
Unlock RNV freeSee plans

Ownership

Free account
Top-20 holders & substantial holder notices
Top-20 register snapshot and substantial-holder movements, each linked to its source notice.
Free account: 2 full company unlocks every month, no card.
Create free account

Latest announcements

28 Oct 2026Becoming a substantial holder
28 Oct 2026Notification regarding unquoted securities - RNV
26 Oct 2026Quarterly Report Webinar
26 Oct 2026$PQ1 FY27 Activities Report and Appendix 4C
19 Oct 2026$PPositive 12-Month Data for NervAlign Nerve Guide Matrix
14 Oct 2026$PPositive FDA Feedback on NervAlign Nerve Guide Matrix
6 Oct 2026Change of Director's Interest Notice - P Savage
6 Oct 2026Change of Director's Interest Notice - M McGuire
6 Oct 2026Change of Director's Interest Notice - J Chick
6 Oct 2026Cleansing Notice
6 Oct 2026Application for quotation of securities - RNV
6 Oct 2026Proposed issue of securities - RNV
6 Oct 2026Notification regarding unquoted securities - RNV
5 Oct 2026Results of Meeting
5 Oct 2026$PReNerve AGM Presentation
21 Sept 2026$PReNerve completes first cases in Hong Kong and Malaysia
14 Sept 2026Change in substantial holding - J Chick
14 Sept 2026Change of Director's Interest Notice - J Chick
7 Sept 2026$PReNerve and RMIT awarded $499k grant
3 Sept 2026Notice of Annual General Meeting/Proxy Form

Headlines link to the source PDFs on the ASX announcements platform. Data as of 28 Oct 2026.